194 related articles for article (PubMed ID: 25925928)
1. Enteropathy-associated T-cell lymphoma: improving treatment strategies.
Nijeboer P; Malamut G; Mulder CJ; Cerf-Bensussan N; Sibon D; Bouma G; Cellier C; Hermine O; Visser O
Dig Dis; 2015; 33(2):231-235. PubMed ID: 25925928
[TBL] [Abstract][Full Text] [Related]
2. Enteropathy-Associated T cell Lymphoma.
Al Somali Z; Hamadani M; Kharfan-Dabaja M; Sureda A; El Fakih R; Aljurf M
Curr Hematol Malig Rep; 2021 Apr; 16(2):140-147. PubMed ID: 34009525
[TBL] [Abstract][Full Text] [Related]
3. Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.
Sieniawski MK; Lennard AL
Curr Hematol Malig Rep; 2011 Dec; 6(4):231-40. PubMed ID: 21912848
[TBL] [Abstract][Full Text] [Related]
4. Enteropathy-associated T-cell lymphoma.
Ferreri AJ; Zinzani PL; Govi S; Pileri SA
Crit Rev Oncol Hematol; 2011 Jul; 79(1):84-90. PubMed ID: 20655757
[TBL] [Abstract][Full Text] [Related]
5. [Early relapse after autologous peripheral blood stem cell transplantation in an elderly patient with enteropathy-associated T-cell lymphoma].
Sumii Y; Yamamoto K; Omura Y; Oda W; Kondo E; Oyama T; Kamoi C; Shiraishi Y; Yamamoto Y; Niiya D; Shiote Y; Imajo K
Rinsho Ketsueki; 2018; 59(7):889-894. PubMed ID: 30078799
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Sieniawski M; Angamuthu N; Boyd K; Chasty R; Davies J; Forsyth P; Jack F; Lyons S; Mounter P; Revell P; Proctor SJ; Lennard AL
Blood; 2010 May; 115(18):3664-70. PubMed ID: 20197551
[TBL] [Abstract][Full Text] [Related]
7. Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysis.
Awad AK; Awan RU; Awad AK; Nabeel A; Dar S; Abegunde AT
Cancer Treat Res Commun; 2023; 36():100745. PubMed ID: 37499419
[TBL] [Abstract][Full Text] [Related]
8. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of refractory enteropathy-associated T-cell lymphoma using high-dose chemotherapy and autologous stem cell transplantation.
Ikebe T; Miyazaki Y; Abe Y; Urakami K; Ohtsuka E; Saburi Y; Saburi M; Ando T; Kohno K; Ogata M; Kadota J
Intern Med; 2010; 49(19):2157-61. PubMed ID: 20930447
[TBL] [Abstract][Full Text] [Related]
10. How I treat enteropathy-associated T-cell lymphoma.
Di Sabatino A; Biagi F; Gobbi PG; Corazza GR
Blood; 2012 Mar; 119(11):2458-68. PubMed ID: 22271451
[TBL] [Abstract][Full Text] [Related]
11. Enteropathy associated T-cell lymphoma and its precursor lesions.
van de Water JM; Cillessen SA; Visser OJ; Verbeek WH; Meijer CJ; Mulder CJ
Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):43-56. PubMed ID: 20206108
[TBL] [Abstract][Full Text] [Related]
12. A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma.
de Baaij LR; Berkhof J; van de Water JM; Sieniawski MK; Radersma M; Verbeek WH; Visser OJ; Oudejans JJ; Meijer CJ; Mulder CJ; Lennard AL; Cillessen SA
Clin Cancer Res; 2015 Jul; 21(13):3013-9. PubMed ID: 25779949
[TBL] [Abstract][Full Text] [Related]
13. A rare but potentially fatal cause of diarrhoea and weight loss: enteropathy-associated T-cell lymphoma.
Wali GN; Tyrrell HE; Collins GP; Eagleton HJ
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25568262
[TBL] [Abstract][Full Text] [Related]
14. [Successful therapy for enteropathy-associated peripheral T-cell lymphoma using high-dose polychemotherapy and autologous hematopoietic stem cell transplantation].
Vorob'ev VI; Kravchenko SK; Kovrigina AM
Ter Arkh; 2013; 85(7):79-83. PubMed ID: 24137952
[TBL] [Abstract][Full Text] [Related]
15. Enteropathy-associated T-cell Lymphoma (EATL) with intracranial metastasis : a rare and dismal condition.
Chuah YY; Tashi T; Lee YY; Fu TY; Shih CA
Acta Gastroenterol Belg; 2020; 83(1):77-80. PubMed ID: 32233276
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.
Jantunen E; Boumendil A; Finel H; Luan JJ; Johnson P; Rambaldi A; Haynes A; Duchosal MA; Bethge W; Biron P; Carlson K; Craddock C; Rudin C; Finke J; Salles G; Kroschinsky F; Sureda A; Dreger P;
Blood; 2013 Mar; 121(13):2529-32. PubMed ID: 23361910
[TBL] [Abstract][Full Text] [Related]
17. Advanced enteropathy-associated T cell lymphoma (EATL) presenting with severe malabsorption and concomitantly diagnosed coeliac disease (CD).
Rajagopal A; Thompson CA; Chorzempa AK; Ryu AJ
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38142052
[TBL] [Abstract][Full Text] [Related]
18. Brentuximab in the treatment of CD30-positive enteropathy-associated T-cell lymphoma.
Khalaf WF; Caldwell ME; Reddy N
J Natl Compr Canc Netw; 2013 Feb; 11(2):137-40; quiz 140. PubMed ID: 23411380
[TBL] [Abstract][Full Text] [Related]
19. Update on the Pathogenesis of Enteropathy-Associated T-Cell Lymphoma.
Abdullah SAA; Goa P; Vandenberghe E; Flavin R
Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627888
[TBL] [Abstract][Full Text] [Related]
20. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
